Biovail recovers from Tuesday selloff
Article Abstract:
San Diego, Calif.-based DJ Pharma Inc. will be acquired by Mississauga, Ont.-based Biovail Corp. for $162.5 million. Biovail may introduce its generic version of the heart drug Tiazac in 2002.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Biovail buys rights to leading heart drug
Article Abstract:
Biovail Corp. has acquired the North American rights to the heart medication, Cardizem for $409.5 million (U.S.). The rights were bought from the French pharmaceutical giant, Aventis S.A.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Biovail shares hit 52-week high (Biovail Corp., reports strong earnings)
Article Abstract:
Mississauga-based pharmaceuticals firm Biovail Corp., reports strong earnings for the year 2000, with revenue expected to be between $540 and $570 million, compared to last year's $309.2 million. Biovail's stock closed at $71.55, the highest for the year.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Magazines closely weigh ad rates for the fourth quarter and early 2002 in a moribund market. Forbes and Fortune are trying to bolster circulation among business movers and shakers
- Abstracts: Coke hopes nostalgia sells with holiday advertising campaign. Coke to target lige stages, styles in new ads
- Abstracts: For first time, Coke puts kids of color on collectible cans. Reinemund faces Pepsi challenge
- Abstracts: Car rental companies unload part of fleets as business falls. Business travel falls as airfares climb, earnings drop
- Abstracts: Canadian Standard Life policy holders could reap huge windfall. Big top gets bigger for Cirque du Soleil